Recruitment

Recruitment Status
Completed

Inclusion Criteria

has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin

Exclusion Criteria

pregnancy
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
...
pregnancy
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
has type 2 diabetes non-pharmacologically treated
has type 2 diabetes treated with multiple daily injections of insulin
is unable to use the telemedicine system

Summary

Conditions
Type 2 Diabetes Mellitus
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)

Participation Requirements

Age
Between 45 years and 125 years
Gender
Both males and females

Inclusion Criteria

has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin

Exclusion Criteria

pregnancy
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
...
pregnancy
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
has type 2 diabetes non-pharmacologically treated
has type 2 diabetes treated with multiple daily injections of insulin
is unable to use the telemedicine system

Tracking Information

NCT #
NCT02194608
Collaborators
Not Provided
Investigators
Not Provided